ANI Pharmaceuticals, Inc. (ANIP) NASDAQ
80.14
+0.2(+0.25%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.58B |
| Enterprise Value | 1.62B |
| P/E Ratio | 21.11 |
| PEG Ratio | 0.2 |
| Price/Sales Ratio | 2.03 |
| Price/Book Ratio | 2.96 |
| Enterprise/Revenue | 2.07 |
| Enterprise/EBITDA | 8.11 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 0.09 |
| Operating Margin | 0.13 |
Management Effectiveness
| Return On Assets | 0.05 |
| Return On Equity | 0.16 |
Income Statement
| Revenue | 883.37M |
| Revenue/Share | 44.05 |
| Gross Profit | 450.64M |
| EBITDA | 207.27M |
| Net Income | 78.34M |
| Diluted EPS | 3.32 |
Balance Sheet
| Total Cash | 285.58M |
| Total Cash/Share | 14.24 |
| Total Debt | 325.2M |
| Total Debt/Equity | 0.6 |
| Current Ratio | 2.71 |
| Book Value Per Share | 26.96 |
Price History
| 52-Week Change | 15.84 |
| 52-Week High | 99.5 |
| 52-Week Low | 56.71 |
| Moving Average 50 Days | 76.34 |
| Moving Average 200 Days | 82.13 |
Statistics
| Average Volume | 379,437 |
| Shares Outstanding | 22.41M |
| % Held by Institutions | 105.44 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0.02 |
| Last Split Factor | 1:6 |
| Last Split Date | July 18, 2013 |
